SCHEMBL24740255

SCHEMBL24740255

CC(C)NC(=O)OCc1cccc(Cl)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.58
HPGD P15428 1/20 0.58
HCAR2 Q8TDS4 1/20 0.52
MMP1 P03956 1/20 0.52
MMP2 P08253 1/20 0.52
MMP9 P14780 1/20 0.52
MMP12 P39900 1/20 0.52
HTT P42858 2/20 0.49
LMNA P02545 2/20 0.49
MEN1 O00255 1/20 0.49
MAPT P10636 1/20 0.49
ALOX12 P18054 1/20 0.49
PTPN7 P35236 1/20 0.49
OPRD1 P41143 1/20 0.49
OPRK1 P41145 1/20 0.49
KMT2A Q03164 1/20 0.49
TSHR P16473 2/20 0.48
KDM4E B2RXH2 1/20 0.48
MAOA P21397 2/20 0.48
MAOB P27338 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6148841 0.85 ADAMTS4 (0.53) ALDH1A1HPGDHCAR2MMP1MMP2
SCHEMBL27433761 0.84 CYP3A4 (0.48) ALDH1A1TSHRCYP3A4ATMTOP2A
SCHEMBL23849386 0.83 HCAR2 (0.56) ALDH1A1HPGDHCAR2MMP1MMP2
SCHEMBL25526937 0.83 CTSK (0.58) ALDH1A1HPGD
SCHEMBL28951822 0.83 CTSK (0.58) ALDH1A1HPGD
SCHEMBL25758739 0.82 ALDH1A1 (0.52) ALDH1A1HPGDHCAR2MMP1MMP2
SCHEMBL6945406 0.82 CTSL (0.56) ALDH1A1HPGDHCAR2MMP1MMP2
SCHEMBL7975207 0.81 ALDH1A1 (0.60) ALDH1A1HPGDHCAR2MMP1MMP2
SCHEMBL24019747 0.81 CTSL (0.47) ALDH1A1HPGDHTTLMNAMEN1
SCHEMBL308291 0.81 ATM (0.64) ALDH1A1TSHRCYP3A4ATMTOP2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212152-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. 2023-07-06 US disclosed
US-11524940-B1 Inhibitors of cysteine proteases and methods of use thereof Pardes Biosciences, Inc. (US) 2022-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11524940-B1 Inhibitors of cysteine proteases and methods of use thereof CTRL, CTSV, CTSL ALDH1A1 2252/4885HPGD 1608/4885HCAR2 4453/4885
US-20230212152-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF CTRL, CTSL, CTSV ALDH1A1 1863/4885HPGD 1219/4885HCAR2 4309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.